Elsevier logo

Publisher: Elsevier

Related content
Volume 57, Number 4, April 1996

< previous issue | all issues | next issue >

Multicenter studies of ultra-high-dose, short-duration streptokinase treatment of deep vein thrombosis
pp. 251-267(17)
Authors: Pilger E.; Eriksson H.; Grungreiff K.; Carlsson A.; Talstad I.; Anders O.; Schuchardt C.; Munck D.; Lafer M.

Treatment with recombinant human granulocyte colony-stimulating factor after chemotherapy for acute myeloid leukemia
pp. 268-277(10)
Authors: Yonekura S.; Kawada H.; Watanabe S.; Satoh H.; Ogawa Y.; Masumoto A.; Fukuda R.; Umeda Y.; Arimori K.; Kobuta N.; Nagao T.

Role of thyroid hormone in protecting against gentamicin-induced nephrotoxicity
pp. 278-287(10)
Authors: Gomes G.N.; Costa Silva V.L.; Cavanal M.D.F.; Gil F.Z.

Bioavailability study of two different formulations of azithromycin
pp. 288-298(11)
Authors: Ferrante L.; Bompadre S.; Cingolani M.L.; Leone L.; Ripa S.

Trials in special populations - Editorial comment
pp. 299-299(1)
Author: Walson P.D.

Amlodipine versus nifedipine in the treatment of mild-to-moderate hypertension in black Africans
pp. 300-308(9)
Authors: Isah A.O.; Obasohan A.O.; Oyewo E.A.; Ohaju-Obodo J.

Corrections
pp. 309-309(1)
Authors: Corsi M.; Lacerna F.; Laurora G.; Milani M.; Borzone A.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page